Oral Bisphosphonate Use and Risk of Postmenopausal Endometrial Cancer

Overview of attention for article published in Journal of Clinical Oncology, February 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 4 news outlets
twitter: 19 X users

facebook: 4 Facebook pages
guideline: 1 clinical guideline source

Readers on

mendeley: 42 Mendeley

So far, Altmetric has seen 5 public wall posts from 4 users.

Oncólogo Cirujano Cd. Juárez - Dr. Hugo De Nova, 04 Mar 2015

"Oral Bisphosphonate Use and Risk of Postmenopausal Endometrial Cancer" JCO Original Report by Drs. Polly A. Newcomb, Michael N.

American Society of Clinical Oncology, 03 Mar 2015

"Oral Bisphosphonate Use and Risk of Postmenopausal Endometrial Cancer" JCO Original Report by Drs. Polly A. Newcomb, Michael N.

Frenar la Artritis, 01 Mar 2015

Nuevas oportunidades para el denostado bifosfonato:¿ prevención del cáncer? http://t.co/mUvNe4cfe3

Frenar la Artritis, 01 Mar 2015

Nuevas oportunidades para el denostado bifosfonato:¿ prevención del cáncer? http://ow.ly/JMoNq

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 1 additional Facebook posts.